HRTS vs XLV
Tema ETF Trust Tema Heart & Health ETF against State Street Health Care Select Sector SPDR ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
51%
19 shared positions
Fee gap
67 bp
XLV is cheaper
1-year return gap
7.0 pts
XLV is ahead
Larger fund
XLV
$43.5B
Side by side
| HRTS | XLV | |
|---|---|---|
| Fund | Tema ETF Trust Tema Heart & Health ETF | State Street Health Care Select Sector SPDR ETF |
| Issuer | Tema | State Street SPDR |
| Category | Health Care | Health Care |
| Expense ratio | 0.75% | 0.08% |
| Assets | $54M | $43.5B |
| Average daily dollar volume | $83K | $1.3B |
| Listed | Nov 20, 2023 | Dec 16, 1998 |
| FrenzyCap score | 19 | 87 |
| 1-month return | +0.1% | +3.1% |
| 3-month return | −0.5% | +5.8% |
| Year to date | +2.6% | +10.3% |
| 1-year return | +11.2% | +18.2% |
| 30-day volatility | 14.2% | 13.5% |
| Worst drawdown, 1 year | −11.0% | −10.8% |
| Trailing 12-month yield | 1.31% | 1.49% |
| Holdings | 45 | 63 |
| Top 10 weight | 49.1% | 60.4% |
| Look-through P/E | 143.3 | 34.5 |
| Holdings vs fair value | +2.1% | +3.6% |
| Holdings above 200-day average | 72% | 86% |
| Net flow, latest 3 reported months | −$698K thru May 2026 | −$1.1B thru Jun 2026 |
| 30-day implied volatility | 16.5% | 17.7% |
| Holdings as of | as of May 31, 2026SEC filing | as of Oct 8, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
57% of HRTS · 72% of XLV
Sector mix of the stock holdings
| Sector | HRTS | XLV | Gap |
|---|---|---|---|
| Health Care | 70.5% | 88.0% | −17.5% |
| Technology | 6.6% | 9.8% | −3.1% |
| Consumer Staples | 0.0% | 1.8% | −1.8% |
| Industrials | 0.0% | 0.1% | −0.1% |
More: full overlap table · HRTS holdings · XLV holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.